Subscribe to Newsletter

Formulation

Discovery & Development Drug Discovery

Nut a Problem

| Jamie Irvine | 2 min read

Immunotherapy Viaskin Peanut shows promising results in desensitizing peanut-allergic toddlers.

Discovery & Development Drug Discovery

Cancer Treatments for Kids

| Jamie Irvine | 5 min read

Day One Bio commits to creating purposeful treatments for children with life-threatening diseases

Discovery & Development Drug Discovery

Cell Therapy Team Up

| Jamie Irvine | 2 min read

Thermo Fisher Scientific and UCSF launch new cell therapy manufacturing site to accelerate advanced cell therapies development

Discovery & Development Drug Delivery

Clever Chemistry and Cages

| Jamie Irvine | 3 min read

Self-assembling “super-sized” nanocages could encapsulate and deliver drugs to specific targets in the body.

Discovery & Development Formulation

Superbugs Versus Supercomputers

| Jamie Irvine | 2 min read

Developments in antivirulence drug treatments could solve the threat of antimicrobial resistance

Discovery & Development Formulation

The Fountain of Youth

| Jamie Irvine | 6 min read

Anti-aging company – Five Alarm Bio – reveal their discoveries on safe and effective treatments for age-associated diseases and disabilities

Discovery & Development Formulation

Llamas – and Yeast Display – to the Rescue

| Jamie Irvine | 2 min read

Modified screening process optimizes nanobodies for sustainable COVID-19 treatments derived from llamas.

Discovery & Development Drug Delivery

Power List Perspectives: Challenges Facing Cell and Gene Therapy

| Jamie Irvine

Leading pharma industry experts discuss the most pertinent challenges facing cell and gene therapy

Discovery & Development Formulation

T Cell Bright Spark

| 3 min read

An insight into the research fuelling developments for universal cancer immunotherapies

Manufacture Bioprocessing - Upstream & Downstream

mAbs: Not so Sweet

| Neha Mishra, Jesus Zurdo | 9 min read

How fucosylation-deficient CHO cell hosts can help enhance the potency of monoclonal antibody-based biotherapeutics

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register